
Currently out of the existing stock ratings of David Buck, 37 are a BUY (80.43%), 9 are a HOLD (19.57%).
Analyst David Buck, has had 53.93% of price targets met with an average potential upside of 26.55%, reached in 401 days on average. Previously, David Buck worked at B. RILEY, NORTHLAND CAPITAL MARKETS.
David Buck has documented 90 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CORT, Corcept Therapeutics at 04-Feb-2019.
Analyst best performing recommendations are on ENDP (ENDO INTERNATIONAL PLC).
The best stock recommendation documented was for ENDP (ENDO INTERNATIONAL PLC) on 8/7/2018. The price target of $15 was fulfilled within 1 day with a profit of $2.35 (18.58%), with a performance score of 185.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 06-Mar-2025
$324
$93.74 (40.71%)
$319
8 days ago
(12-Nov-2026)
19/25 (76%)
$82.45 (34.13%)
428
Buy Since 23-Feb-2021
$330
$99.74 (43.32%)
$310
9 days ago
(11-Nov-2026)
39/42 (92.86%)
$89.63 (37.29%)
1356
Buy Since 10-Mar-2016
$310
$79.74 (34.63%)
$300
18 days ago
(02-Nov-2026)
20/23 (86.96%)
$80.26 (34.94%)
1608
Buy Since 07-Jul-2025
$305
$74.74 (32.46%)
$296
18 days ago
(02-Nov-2026)
8/10 (80%)
$75.26 (32.76%)
68
Buy Since 26-Feb-2026
$275
$44.74 (19.43%)
$271
18 days ago
(02-Nov-2026)
6/9 (66.67%)
$45.26 (19.70%)
39